Novo Holdings, the owner of Danish pharmaceutical firm Novo Nordisk, is tight-lipped when it comes to the insider trading case surrounding Sir Christopher Gent, former chairman of British medtech firm Convatec, reports Danish business media Børsen.
The Danish investment company bought a share of just under 20% in Convatec for nearly DKK 9bn (USD 1.2bn) in March 2017, and is today represented on the board by former chairman of the Novo Nordisk Foundation Sten Scheibye, who also served as CEO of Coloplast, a competitor to Convatec in several areas.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
FDA fast-tracks Eli Lilly's obesity candidate
Tirzepatide is already approved for type 2 diabetes, and Lilly has been vying for access to the obesity market for a while – the day the drug could be approved in both indications has now been moved up.
Jefferies spots weaknesses in GN
One potential chink in GN’s armor is that the company’s newly announced hearing aid platform, Omnia, isn’t predicted to win significant market shares.
Bavarian initiates new arm of phase III Covid-19 vaccine trial
The first patient has already been dosed in the US, and the Danish vaccine maker is now expanding the study to include Denmark and Belgium.
Fujifilm doubles bottom line in annual report
Despite a 12.5% cost increase compared to the preceding year, Fujifilm Diosynth Biotechnologies managed to increase its profit twofold in 2021/2022.
Life science CEOs' paychecks decrease as markets decline
When the markets are down, everyone is in the same boat, in theory -- however, former Ambu CEO Lars Marcher warns boards against unduly rewarding CEOs by changing pre-existing share-based programs.
KLIFO is looking for a Compliance Coordinator for our Glostrup office 
Senior/lead consultant at Emendo Engineering 
Upstream Processing CMC Specialist 
Chief Business Officer 
Senior CMC & Device Project Manager 
Principal Scientist - Drug Metabolism & Pharmacokinetics 
Senior Project Manager 
Head of department RA/QA/PV, Danmark 
Scientist Radiochemistry 
Pharmacovigilance & Regulatory Officer 
Lab Manager 
Product specialist 
Sales Manager Denmark 
Experienced IT Business Solutions Manager for the Danish Medicines Agency 
Orifarm Healthcare Product Development PMO Director